- Report
- April 2023
- 80 Pages
Ireland
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 80 Pages
India
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 80 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 80 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 80 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 80 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 80 Pages
Argentina
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 80 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2023
- 255 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Drug Pipelines
- January 2020
- 1500 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- August 2023
- 117 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- April 2023
- 100 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- July 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- November 2021
- 656 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2022
- 309 Pages
Global
From €3651EUR$3,840USD£3,067GBP
- Book
- December 2011
- 492 Pages
The Peptide Therapeutic market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Peptide Therapeutics are a type of drug that are composed of short chains of amino acids, and are used to treat a variety of diseases. These drugs are typically used to target specific proteins in the body, and can be used to treat conditions such as cancer, diabetes, and autoimmune diseases. Peptide Therapeutics are often used in combination with other drugs, such as chemotherapy, to maximize their effectiveness.
The Peptide Therapeutic market is highly competitive, with many companies developing and marketing these drugs. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Sanofi. Other companies such as AbbVie, AstraZeneca, and Eli Lilly are also active in the market. Show Less Read more
